HIGHLIGHTS
- who: December et al. from the Dalian Medical University, China have published the Article: Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study, in the Journal: (JOURNAL)
- what: The analysis showed that the instrument caused a decrease of 0.988 (95%CI 0.985-0.991) mg/L in the CRP level.
- how: The authors conducted a mendelian randomization analysis using publicly available GWAS data to examine the association between genetically proxied inhibition of TNFR1 and the risk of colorectal cancer. The three . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.